List of Top 10 Based Rabies Vaccines Brands Popular in European and American Countries

May 06, 2024

The global market for rabies vaccines is projected to experience significant growth due to increasing awareness about the importance of vaccination in preventing this deadly virus. Based rabies vaccines, which are derived from inactivated rabies virus, are expected to dominate the market due to their high efficacy and safety profile. With rising incidences of rabies cases worldwide, the demand for these vaccines is expected to surge in the coming years. Major players in the market include Sanofi Pasteur, GlaxoSmithKline, and Merck & Co. Inc.

Rabipur
Imovax
Changchun Zhuoyi Biological Co., Ltd
Verorab
HDCV

Rabipur

Establishment time : 1992

website : www.rabipur.com

Main Product : Rabies vaccine

Company Profile

Rabipur is a leading pharmaceutical company specializing in the production of rabies vaccines. Established in 1992, the company has grown to become a major player in the global market, providing high-quality vaccines to prevent rabies infection. With a large presence and a strong reputation in the industry, Rabipur continues to innovate and expand its product offerings to meet the needs of customers worldwide.

Imovax

Establishment time : Imovax is a leading vaccine manufacturer with a long history of providing high-quality products.

website :

Main Product : Imovax's main focus is on developing vaccines for a variety of diseases, including influenza, measles, and hepatitis.

Company Profile

Overall, Imovax is dedicated to improving public health through the development and distribution of life-saving vaccines.

Changchun Zhuoyi Biological Co., Ltd

Establishment time : 2005

website : www1.zhuoyi-bio.com

Main Product : Human Rabies Vaccine,Rabies Prevention ,Freeze-dried Human Rabies Vaccine ,Rabies Vaccine,Human Rabies Vaccination,Human Rabies Vaccine and Infant

Company Profile

Changchun Zhuoyi Biological Co., Ltd., located in Shuangyang Economic Development Zone of Changchun City, is a key vaccine manufacturer invested by Zhejiang SelCorning Biotechnology Co., Ltd. in Jilin Province, and a vice chairman unit of Zhejiang Chamber of Commerce in Jilin Province. The company was founded on January 27, 2005. Mr. Feng Xingfu, chairman and general manager of the company, graduated from the Department of Biology, University of Science and Technology of China, and has been engaged in the marketing and enterprise management of biological products since the 1980s. The company has a registered capital of one hundred and one million six hundred and ninety-two thousand seven hundred and eighty-four yuan, covers an area of 41600 square meters, and has the leading vaccine research and development and production capacity in China. Changchun Zhuoyi Biological Co., Ltd. is a new vaccine manufacturer integrating R&D, production and sales. At present, the biological products approved by the company are mainly Rabies Vaccine (Vero cell) for Human Use, Freeze-dried. The company successfully passed the two in one inspection at the end of 2016 and obtained the registration approval and GMP certificate, which was officially put into production in January 2017. The company's existing production workshop covers an area of about 5700 square meters, with a cumulative investment of 400 million yuan. At present, the maximum annual output is 1 million people. The second phase workshop has been completed at the end of 2018, and will be officially produced in 2020. By then, the production capacity can reach 4 million people. The company has nearly 2000 square meters of pilot scale research workshop, advanced equipment such as bioreactor, ultrafiltration system, AKTA purification workstation, fluorescence microscope, etc., which are used for virus culture, improvement of purification system and identification of recombinant protein. The company has maintained close scientific research cooperation with many scientific research institutions at home and abroad. At present, the company is developing a serum rabies vaccine and a broad-spectrum human papillomavirus vaccine jointly developed with the Institute of Basic Medicine of the Chinese Academy of Medical Sciences. It is planned to cooperate with Murdoch Children's Research Institute in Australia to develop the round vaccine project. At the same time, the company also actively explores the path of internationalization. At present, the company has started to register in the Philippines, Pakistan, Cambodia, Bangladesh, Mongolia, Uzbekistan and other countries. It is estimated that the export of finished products in some markets will be realized by 2020. The company's technical cooperation project with Australia is one of the company's many international cooperation projects. The company always adheres to the concept of "standardized management, quality first", and adheres to the core values of "honesty, diligence, innovation, preciseness, learning and happiness", so as to provide high-quality vaccine products to serve the health of the people.

Verorab

Establishment time : Verorab is a rabies vaccine manufactured by Sanofi Pasteur.

website :

Main Product : Verorab is a highly effective and safe vaccine that is used for both pre-exposure and post-exposure prophylaxis against rabies.

Company Profile

With a large company size and strong competitive position, Sanofi Pasteur continues to be a trusted provider of rabies vaccines.

HDCV

Establishment time : HDCV was established in 2005.

website :

Main Product : HDCV's main products include electronic components and devices.

Company Profile

HDCV is a leading supplier of high-quality electronic components and devices.